The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Retrospective analysis of prognostic factors in non-small cell lung cancer with EGFR mutations.
Shingo Nishikawa
No relevant relationships to disclose
Takashi Sone
No relevant relationships to disclose
Taro Yoneda
No relevant relationships to disclose
Kazuhiko Shibata
No relevant relationships to disclose
Koji Kurokawa
No relevant relationships to disclose
Toshiyuki Kita
No relevant relationships to disclose
Hiroki Shirasaki
No relevant relationships to disclose
Kazuyoshi Watanabe
No relevant relationships to disclose
Hideharu Kimura
No relevant relationships to disclose
Kazuo Kasahara
Honoraria - Chugai Pharma